FDA Nod For Novartis Drug To Avert Organ Failure In Liver Transplant – NASDAQ
FDA Nod For Novartis Drug To Avert Organ Failure In Liver TransplantNASDAQThe approval also means that Zortress (everolimus) is the first mammalian target of rapamycin (mTOR) inhibitor to prevent organ rejection in adult liver transplant patients in th…

